Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Syntactic and Prosodic Phrasal Alignment in Naturalistic Language.

Cognitive science·2026
Same author

Effects of executive function training on balance and auditory-cognitive dual-task performance in adults with and without hearing loss.

PloS one·2026
Same author

Brushstrokes of Resilience: The Value of Participating in Arts-Based Research from the Perspective of Older Adults Living with HIV.

Canadian journal on aging = La revue canadienne du vieillissement·2026
Same author

Implementing virtual reality training for person-centered communication in dementia care: a longitudinal qualitative study.

Innovation in aging·2026
Same author

'Beyond the Prescription': An Arts-Based Study of Older Adults Living With HIV and Their Primary Care Experiences in Ontario.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

Exploring why there is limited physical rehabilitation for people living with dementia: a qualitative study.

Disability and rehabilitation·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K

Technology and Dementia Preconference.

Raheleh Saryazdi1,2, Lou-Anne Carsault3, Julie Bannon4

  • 1Trent University Durham, Oshawa, ON, Canada.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 23, 2025
PubMed
Summary
This summary is machine-generated.

Virtual Reality (VR) therapy at home improved communication between persons living with dementia (PLwD) and their caregivers more than tablet-only use. The study highlights VR

More Related Videos

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

Related Experiment Videos

Last Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

Area of Science:

  • Gerontology and Aging Research
  • Human-Computer Interaction
  • Dementia Care Technology

Background:

  • Virtual Reality (VR) therapies show promise for improving well-being in persons living with dementia (PLwD).
  • Existing VR research for PLwD is primarily in institutional settings, with limited focus on at-home use and family caregiver interaction.
  • This study addresses the gap by evaluating VR for enhancing PLwD and family caregiver communication in a home environment.

Purpose of the Study:

  • To assess the efficacy of an at-home VR intervention (VRx@Home) in facilitating communication between PLwD and family caregivers.
  • To compare the effectiveness of VR technology against traditional tablet-based technology for improving communication.
  • To explore user preferences and gather feedback on technology adoption for in-home dementia care.

Main Methods:

  • Families participated in an at-home training and baseline data collection.
  • Intervention involved 2 weeks of either VR (with paired tablet) or tablet-only use, with weekly remote researcher sessions and independent use.
  • Data collected included communication measures, technology preferences, and general feedback via semi-structured interviews.

Main Results:

  • Preliminary results indicate both VR and tablet interventions improved communication (frequency, engagement, duration) compared to baseline.
  • VR demonstrated a greater extent of communication improvement than the tablet-only condition.
  • Entertainment and animal themes were favored; user preferences for VR versus tablet varied, emphasizing the need for options.

Conclusions:

  • VR therapy is feasible for at-home implementation and can significantly enhance communication between PLwD and caregivers.
  • User preferences for technology (VR vs. tablet) are variable, underscoring the importance of offering choices for sustained at-home adoption.
  • Future research should consider personalized technology options to maximize engagement and therapeutic benefits for PLwD and their families.